This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rodrigo, M. J. Articles by Morell, F. Search for Related Content PubMed PubMed Citation Articles by Rodrigo, M. J. Articles by Morell, F.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 03 1997, 168-172, Vol 4, No. 2
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria

MJ Rodrigo, M Miravitlles, MJ Cruz, J de Gracia, M Vendrell, C Pascual and F Morell
Department of Biochemistry (Immunology Unit), Hospital General Vall d'Hebron, Barcelona, Spain.

The aim of the study was to standardize an enzyme-linked immunosorbent assay (ELISA) method for the quantification of immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine and to establish the criteria for a normal response to the vaccine. Forty healthy individuals (20 women and 20 men; mean age, 29 years) were studied. All were vaccinated with the 23-valent pneumococcal vaccine; blood samples were drawn just prior to and 3 weeks after immunization. Quantification of specific IgG and its subclasses was performed by an ELISA with the vaccine as the antigen. The linearity of the ELISA method was demonstrated by the similar slopes of the linear regression lines generated from the titration of sera with different antibody concentrations. The specificity of the antibodies against the vaccine was demonstrated by (i) an absorption test with pneumococcal vaccine, (ii) a cross-reactivity experiment with Haemophilus influenzae type b polysaccharide, and (iii) affinity chromatography with protein A-Sepharose. Response to the vaccine was defined by using the lower level of the 90% probability interval (one- tailed) for postimmunization-specific IgG, IgG1, and IgG2. By using this cutoff, responders were considered to be those with an absolute increase in antibody titers higher than 395 arbitrary units/ml for IgG, 0.350 A450 units for IgG1, and 0.314 A450 units for IgG2. Overall, 20 (50%) subjects had IgG, IgG1, and IgG2 responses, 9 (22.5%) had IgG and IgG2 responses, 4 (10%) had IgG1 responses, 3 (7.5%) had IgG and IgG1 responses, and 4 (10%) were nonresponders. Ninety percent of our population responded to the 23-valent pneumococcal vaccine. Up to 10% of healthy individuals may respond to an IgG subclass without significant increases in total IgG titers. The ELISA method that is described may be useful for evaluating the specific antibody response against polysaccharides.

This article has been cited by other articles:

• Miravitlles, M., Vendrell, M., de Gracia, J. (2005). Antibody deficiency in bronchiectasis. Eur Respir J 26: 178-180 [Full Text]  
• Vendrell, M., de Gracia, J., Rodrigo, M.-J., Cruz, M.-J., Alvarez, A., Garcia, M., Miravitlles, M. (2005). Antibody Production Deficiency With Normal IgG Levels in Bronchiectasis of Unknown Etiology. Chest 127: 197-204 [Abstract] [Full Text]  
• Barker, A. F. (2002). Bronchiectasis. NEJM 346: 1383-1393 [Full Text]  
• PASTEUR, M. C., HELLIWELL, S. M., HOUGHTON, S. J., WEBB, S. C., FOWERAKER, J. E., COULDEN, R. A., FLOWER, C. D., BILTON, D., KEOGAN, M. T. (2000). An Investigation into Causative Factors in Patients with Bronchiectasis. Am. J. Respir. Crit. Care Med. 162: 1277-1284 [Abstract] [Full Text]  
• RODRIGO, M.-J., VENDRELL, M., CRUZ, M.-J., MIRAVITLLES, M., PASCUAL, C., MORELL, F., DE GRACIA, J. (2000). Utility of the Antibody Response to a Conjugated Haemophilus influenzae Type B Vaccine for Diagnosis of Primary Humoral Immunodeficiency. Am. J. Respir. Crit. Care Med. 162: 1462-1465 [Abstract] [Full Text]  
• Rodrigo, M J, Benavent, M I, Cruz, M J, Rosell, M, Murio, C, Pascual, C, Morell, F (2000). Detection of specific antibodies to pigeon serum and bloom antigens by enzyme linked immunosorbent assay in pigeon breeder's disease. Occup. Environ. Med. 57: 159-164 [Abstract] [Full Text]  
• Miravitlles, M., de Gracia, J., Rodrigo, M.-J., Cruz, M.-J., Vendrell, M., Vidal, R., Morell, F. (1999). Specific Antibody Response Against the 23-Valent Pneumococcal Vaccine in Patients With {alpha}1-Antitrypsin Deficiency With and Without Bronchiectasis. Chest 116: 946-952 [Abstract] [Full Text]